These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38354501)

  • 41. Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma.
    Bai YP; Yang CJ; Deng N; Zhang M; Zhang ZJ; Li L; Zhou Y; Luo XF; Xu CR; Zhang BQ; Ma Y; Liu YQ
    Biochem Pharmacol; 2022 Jun; 200():115049. PubMed ID: 35469784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation.
    Hawash M; Kahraman DC; Cetin-Atalay R; Baytas SN
    Chem Biodivers; 2021 May; 18(5):e2001037. PubMed ID: 33713038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma.
    Eissa IH; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; Abdelhady AA; Elhendawy MA; Radwan MM; ElSohly MA; Mahdy HA
    Bioorg Chem; 2021 Feb; 107():104532. PubMed ID: 33334586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tigliane-and daphnane-type diterpenoids from the buds of
    Chen Y; Zhao CL; Dong W; Song FF; Guo LN; Zhang HL; Zhen L; Li L; Ye J; Song B
    Nat Prod Res; 2023; 37(18):3163-3169. PubMed ID: 36382781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.
    Wu J; Guo L; Qiu X; Ren Y; Li F; Cui W; Song S
    Br J Cancer; 2020 Nov; 123(11):1673-1685. PubMed ID: 32958824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Daphne genkwa diterpenes: fingerprint and quantitative analysis by high performance liquid chromatography.
    Zhang S; Zhang F; Li X; Dong W; Wen L; Wang S
    Phytochem Anal; 2007; 18(2):91-7. PubMed ID: 17439007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents.
    Cao W; Yu P; Yang S; Li Z; Zhang Q; Liu Z; Li H
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phytochemical analysis of Daphne pontica L. stems with their pro-apoptotic properties against DU-145 and LNCaP prostate cancer cells.
    Nikahd M; Aghaei M; Ali Z; Sajjadi SE; Khan IA; Ghanadian M
    Daru; 2022 Jun; 30(1):85-101. PubMed ID: 35195873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
    Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
    J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arsenic trioxide-induced upregulation of miR-1294 suppresses tumor growth in hepatocellular carcinoma by targeting TEAD1 and PIM1.
    Cai X; Yu L; Chen Z; Ye F; Ren Z; Jin P
    Cancer Biomark; 2020; 28(2):221-230. PubMed ID: 32280078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
    Li H; Lan H; Zhang M; Zhao F; An N; Yi C
    Dig Dis Sci; 2023 Jul; 68(7):3070-3082. PubMed ID: 36680650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular carcinoma.
    Qiao R; Fan X; Zhou L; Dong D; Liu Y; Liu D; Ma G; Tang N; Wang Y; Li XQ; Ren L; Cao W
    Future Med Chem; 2023 Apr; 15(7):629-646. PubMed ID: 37132400
    [No Abstract]   [Full Text] [Related]  

  • 54. 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.
    Chaudhary CL; Lim D; Chaudhary P; Guragain D; Awasthi BP; Park HD; Kim JA; Jeong BS
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):844-856. PubMed ID: 35296193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma.
    Lai YL; Wang KH; Hsieh HP; Yen WC
    J Biomed Sci; 2022 Jan; 29(1):5. PubMed ID: 35062934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stachydrine hydrochloride inhibits hepatocellular carcinoma progression via LIF/AMPK axis.
    Bao X; Liu Y; Huang J; Yin S; Sheng H; Han X; Chen Q; Wang T; Chen S; Qiu Y; Zhang C; Yu H
    Phytomedicine; 2022 Jun; 100():154066. PubMed ID: 35366490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: synthesis, preliminary structure-activity relationships, and in vitro biological evaluation.
    Zeng XX; Zheng RL; Zhou T; He HY; Liu JY; Zheng Y; Tong AP; Xiang ML; Song XR; Yang SY; Yu LT; Wei YQ; Zhao YL; Yang L
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6282-5. PubMed ID: 20846862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Daphnane-type diterpenes from genus
    Hou ZL; Yao GD; Song SJ
    Chin Herb Med; 2021 Apr; 13(2):145-156. PubMed ID: 36117500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological Screening and Radiolabeling of Raptinal as a Potential Anticancer Novel Drug in Hepatocellular Carcinoma Model.
    Haffez H; Taha H; Farrag NS; Amin AM; Hassan ZA
    Eur J Pharm Sci; 2021 Mar; 158():105653. PubMed ID: 33253882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of novel derivatives of gambogic acid as anti-hepatocellular carcinoma agents.
    He L; Ling Y; Fu L; Yin D; Wang X; Zhang Y
    Bioorg Med Chem Lett; 2012 Jan; 22(1):289-92. PubMed ID: 22153338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.